Background And Objective: Malignant ventricular arrhythmias (MAs) occur unpredictably and lead to emergencies. A new approach that uses a timely tracking device e.g., photoplethysmogram (PPG) solely to predict MAs would be irreplaceably valuable and it is natural to expect the approach can predict the occurrence as early as possible.
Method: We assumed that with an appropriate metric based on signal complexity, the heartbeat interval time series (HbIs) can be used to manifest the intrinsic characteristics of the period immediately precedes the MAs (preMAs). The approach first characterizes the patterns of preMAs by a new complexity metric (the refined composite multi-scale entropy). The MAs detector is then constructed by checking the discriminability of the MAs against the sinus rhythm and other prevalent arrhythmias (atrial fibrillation and premature ventricular contraction) of three machine-learning models (SVM, Random Forest, and XGboost).
Results: Two specifications are of interest: the length of the HbIs needed to delineate the preMAs patterns sufficiently (l) and how long before the occurrence of MAs will the HbIs manifest specific patterns that are distinct enough to predict the impending MAs (t). Our experimental results confirmed the best performance came from a Random-Forest model with an average precision of 99.99% and recall of 88.98% using a HbIs of 800 heartbeats (the l), 108 seconds (the t) before the occurrence of MAs.
Conclusion: By experimental validation of the unique pattern of the preMAs in HbIs and using it in the machine learning model, we showed the high possibility of MAs prediction in a broader circumstance, which may cover daily healthcare using the alternative sensor in HbIs monitoring. Therefore, this research is theoretically and practically significant in cardiac arrest prevention.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2021.106102 | DOI Listing |
Sci Rep
January 2025
Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
To investigate how PD-L1 monoclonal antibodies (mAbs) affect the left ventricular function in mice with myocardial infarction (MI) and through what mechanisms they exert their effects. In vivo experiments were conducted using 27 female BALB/c mice, which were divided equally into 3 groups. Cardiac function was assessed by ultrasound.
View Article and Find Full Text PDFJACC Case Rep
January 2025
Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA.
Left ventricular outflow tract (LVOT) obstruction is mostly caused by hypertrophic obstructive cardiomyopathy and subaortic stenosis. Rarely, malignancy can lead to dynamic LVOT obstruction and has only been sporadically documented. We present the first case of dynamic and/or nearly fixed LVOT obstruction caused by a cardiac myxoid spindle cell sarcoma.
View Article and Find Full Text PDFJACC Case Rep
December 2024
Division of Cardiac Surgery, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
Metastatic disease is a relative contraindication for resection of malignant cardiac tumors. However, certain situations may present themselves when primary cardiac resection may be warranted. We present a 21-year-old male diagnosed with metastatic epithelioid hemangioendothelioma with right ventricular outflow tract involvement for whom surgical resection was successfully performed and discuss strategies.
View Article and Find Full Text PDFActa Neurochir (Wien)
January 2025
Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), Neurosurgical Unit, University of Palermo, Palermo, Italy.
Objective: Communicating hydrocephalus (CH) is an uncommon complication that can affect patients with glioblastoma (GBM). Due to its clinical and radiological findings, it presents as a chronic hydrocephalus. The mechanisms underlying its occurrence and impact on the prognosis of the disease are poorly known, but some studies have suggested that shunting can have a positive impact on the quality of life of these patients.
View Article and Find Full Text PDFCardiovasc Toxicol
January 2025
Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.
Doxorubicin (DOX) is an important drug used in the treatment of many malignancies. Unfortunately DOX causes various side effects, with cardiotoxicity being the most characteristic. Risk factors for DOX induced cardiotoxicity (DIC) include cumulative dose of DOX, preexisting cardiovascular diseases, dyslipidemia, diabetes, smoking, along with the use of other cardiotoxic agents.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!